Treatment of inflammatory acne with a combination therapy with lymecycline and adapalene followed by maintenance treatment with adapalene

European Journal of Inflammation

Volumn 2, Issue 1, 2004, Pages 45-52

  Cassano, N ^a   Amoruso, A ^b   Alessandrini, G ^b   Biuso, A ^b   Carrieri, G ^b   Fai, D ^b   Gabellone, M ^b   Ligori, P ^b   Malvindi, C ^b   Mancino, A ^b   Mangano, R ^b   Mannino, V ^b   Martina, G ^b   Messina, V ^b   Pelle, S ^b   Randazzo, F ^b   Randazzo, G ^b   Ricciuti, F ^b   Ruggiero, A ^b   Senia, G ^b   Serrati, E ^b   Sodo, M R ^b   Stasi, R ^b   Vena, G A ^b   more..

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Adapalene; Inflammatory acne vulgaris; Lymecycline; Treatment

Indexed keywords

ADAPALENE; DOXYCYCLINE; LYMECYCLINE; MINOCYCLINE; RETINOID DERIVATIVE; TETRACYCLINE DERIVATIVE;

ACNE VULGARIS; ADOLESCENT; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DIPLOPIA; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG FORMULATION; DRUG RESPONSE; DRUG TOLERABILITY; DRY SKIN; ERYTHEMA; FEMALE; GASTROINTESTINAL SYMPTOM; GEL; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PATIENT SATISFACTION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRURITUS; SCORING SYSTEM; SEBORRHEA; SKIN BURNING SENSATION; SKIN IRRITATION;

EID: 2942537875     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X0400200107     Document Type: Article

References (23)

1. Cunliffe W.J. and N.B. Simpson. 1998. Disorders of the sebaceous glands. In Textbook of Dermatology. R.H. Champion, J.L. Burton, D.A. Burns Braethnach S.M., ed. Blackwell Science Ltd. Oxford, p. 1927.
2. Hurwitz S. 1990. Acne vulgaris: its pathogenesis and management. Adolesc. Med. 1:301.
3. Oberemok S.S. and A.R. Shalita. 2002. Acne vulgaris, I: pathogenesis and diagnosis. Cutis 70:101.
4. Gollnick H. 2003. Current concepts of the pathogenesis of acne: implications for drug treatment. Drugs 63:1579.
5. Meynadier J. and M. Alirezai. 1998. Systemic antibiotics for acne. Dermatology 196:135.
6. Thiboutot D. 2000. New treatments and therapeutic strategies for acne. Arch. Fam. Med. 9:179.
7. Cunliffe W.J. and H. Gollnick. 2001. In Acne diagnosis and management. Martin Dunitz London, p. 1.
8. Bernard B.A. 1993. Adapalene, a new chemical entity with retinoid activity. Skin. Pharmacol. 6(S 1):61.
9. Michel S., A. Jomard and M. Démarchez. 1998. Pharmacology of adapalene. Br. J. Dermatol. 139(S 52):3.
10. Hensby C., D. Cavey, M. Bouclier, A. Chatelus, D. Algate, J. Eustache and B. Shroot. 1990. The in vivo and in vitro anti-inflammatory activity of CD271: a new retinoid-like modulator of cell differentiation. Agents Actions 29:56.
11. Sjolin-Forsberg G. and J. Hermansson. 1984. Comparative bioavailability of tetracycline and lymecycline. Br. J. Clin. Pharmacol. 18:529.
12. Grosshans E., S. Belaich, J. Meynadier, M. Alirezai and L. Thomas. 1998. A comparison of the efficacy and safety of lymecycline and minocycline in patients with moderately severe acne vulgaris. Eur. J. Dermatol. 8:161.
13. Bossuyt L., J. Bosschaert, B. Richert, P. Cromphaut, T. Mitchell, M. Al Abadie, I. Henry, A. Bewley, T. Poyner, N. Mann and J. Czernielewski. 2003. Lymecycline in the treatment of acne: an efficacious, safe and cost-effective alternative to minocycline. Eur. J. Dermatol. 13:130.
14. Bjellerup M. and B. Ljunggren. 1994. Differences in phototoxic potency should be considered when tetracyclines are prescribed during summer-time. A study on doxycycline and lymecycline in human volunteers, using an objective method for recording erythema. Br. J. Dermatol. 130:356.
15. Cassano N., G. Alessandrini, G. Carrieri, D. Fai, M. Gabellone, M. Gravante, P. Ligori, A. Mancino, S. Manco, G. Martina G et al. 2003. Adapalene. Profilo farmacologico e terapeutico. G. Ital. Dermatol. Venereol. 138:49.
16. Cunliffe W.J., R. Caputo, B. Dreno, L. Forstrom, M. Heenen, C.E. Orfanos, Y. Privat, A. Robledo Aguilar, J. Meynadier, M. Alirezai M et al. 1997. Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials. J. Am. Acad. Dermatol. 36:S126.
17. Grosshans E., R. Marks, J.M. Mascaro, H. Torras, J. Meynadier, M. Alirezai, A.Y. Finlay, P. Soto, M. Poncet, M. Verschoore and A. Clucas. 1998. Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life. Br. J. Dermatol. 139 (S 52):26.
18. Cunliffe W.J., M. Poncet, C. Loesche and M. Versschoore. 1998. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials. Br. J. Dermatol. 139 (S 52):48.
19. Cunliffe W.J., F.W. Danby, F. Dunlap, M.H. Gold, D. Gratton and A. Greenspan. 2002. Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris. Eur. J. Dermatol. 12:350.
20. Cunliffe W.J., J. Meynadier, M. Alirezai, S.A. George, I. Coutts, D.I. Roseeuw, J.P. Hachem, P. Briantais, F. Sidou and P. Soto. 2003. Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle. J. Am. Acad. Dermatol. 49(S 3):S218.
21. Leyden J.J. 2003. A review of the use of combination therapies for the treatment of acne vulgaris. J. Am. Acad. Dermatol. 49(S 3):S200.
22. Cassano N., M. Carbonara, M. Grandolfo, S. Calabretta, C. Castellana, C. Coviello, S. Curia, S. Dattola, C. De Caro, G. Favero, G. Felice, A. Ferrari, D. Fiorentino, G. Liguori, R. Lopreiato, L. Ottomano, E. Provenzano, F. Salamina, R. Vernaci, G. A. Vena. A multicentre open study on the tolerability and efficacy of a cosmetic treatment in mild acne vulgaris during the summer months. Eur. J. Inflamm. 1:85
23. Cassano N., G. Alessandrini, D. Fai, M. Gabbellone, M. Gravante, P. Ligori, C. Malvindi, A. Mancino, G. Martina, A. Natalizi, M. R. Sodo, E. Serrantì, R. Stasi and G.A. Vena. Treatment of seborrhoeic dermatitis of the scalp with desonide 0.05% solution. Eur. J. Inflamm. 1:91.